Literature DB >> 25015056

CD40 promotes the development of early diabetic retinopathy in mice.

Jose-Andres C Portillo, Jennifer A Greene, Genevieve Okenka, Yanling Miao, Nader Sheibani, Timothy S Kern, Carlos S Subauste.   

Abstract

AIMS/HYPOTHESIS: Microangiopathy is a leading complication of diabetes that commonly affects the retina. Degenerate capillaries are a central feature of diabetic retinopathy. An inflammatory process has been linked to the development of diabetic retinopathy but its regulation is incompletely understood. Cluster of differentiation (CD) 40 is a member of the TNF receptor superfamily that promotes the development of certain inflammatory disorders. The role of CD40 in diabetic microangiopathy is unknown.
METHODS: B6 and Cd40−/− mice were administered streptozotocin to induce diabetes. Leucostasis was assessed using fluorescein isothiocyanate-conjugated concanavalin A. Retinal Icam1 and Cd40 mRNA levels were examined using real-time PCR. Protein nitration was assessed by immunohistochemistry. Histopathology was examined in the retinal vasculature. CD40 expression was assessed by flow cytometry and immunohistochemistry. Intercellular adhesion molecule 1 (ICAM-1) and nitric oxide synthase 2 (NOS2) were examined by immunoblot and/or flow cytometry. Nitric oxide production was examined by immunoblot and Griess reaction.
RESULTS: In mouse models of diabetes, Cd40−/− mice exhibited reduced retinal leucostasis and did not develop capillary degeneration in comparison with B6 mice. Diabetic Cd40−/− mice had diminished ICAM-1 upregulation and decreased protein nitration. Cd40 mRNA levels were increased in the retinas of diabetic B6 mice compared with non-diabetic controls. CD40 expression increased in retinal Müller cells, endothelial cells and microglia of diabetic animals. CD40 stimulation upregulated ICAM-1 in retinal endothelial cells and Müller cells. CD40 ligation upregulated NOS2 and nitric oxide production by Müller cells. CONCLUSIONS/
INTERPRETATION: CD40-deficient mice were protected fromthe development of diabetic retinopathy. These mice exhibited diminished inflammatory responses linked to diabetic retinopathy. CD40 stimulation of retinal cells triggered these pro-inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25015056      PMCID: PMC4291184          DOI: 10.1007/s00125-014-3321-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes.

Authors:  P A Kiener; P Moran-Davis; B M Rankin; A F Wahl; A Aruffo; D Hollenbaugh
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

2.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.

Authors:  V Henn; J R Slupsky; M Gräfe; I Anagnostopoulos; R Förster; G Müller-Berghaus; R A Kroczek
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

3.  Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

Authors:  Ling Zheng; Csaba Szabó; Timothy S Kern
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

4.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.

Authors:  M Mizutani; T S Kern; M Lorenzi
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes.

Authors:  A Capetandes; M E Gerritsen
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-09       Impact factor: 4.799

6.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

7.  Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.

Authors:  Nerea Varo; David Vicent; Peter Libby; Rebecca Nuzzo; Alfonso L Calle-Pascual; María Rosa Bernal; Arturo Fernández-Cruz; Aristidis Veves; Petr Jarolim; Jose Javier Varo; Allison Goldfine; Edward Horton; Uwe Schönbeck
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

9.  Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation.

Authors:  M Yngen; C-G Östenson; H Hu; N Li; P Hjemdahl; N H Wallén
Journal:  Diabetologia       Date:  2004-02-13       Impact factor: 10.122

10.  CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

Authors:  K Karmann; C C Hughes; J Schechner; W C Fanslow; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more
  22 in total

1.  Identification of Signaling Pathways by Which CD40 Stimulates Autophagy and Antimicrobial Activity against Toxoplasma gondii in Macrophages.

Authors:  Elizabeth Liu; Yalitza Lopez Corcino; Jose-Andres C Portillo; Yanling Miao; Carlos S Subauste
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

2.  Diabetes enhances translation of Cd40 mRNA in murine retinal Müller glia via a 4E-BP1/2-dependent mechanism.

Authors:  Sadie K Dierschke; Allyson L Toro; William P Miller; Siddharth Sunilkumar; Michael D Dennis
Journal:  J Biol Chem       Date:  2020-05-31       Impact factor: 5.157

3.  Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling.

Authors:  Jose-Andres C Portillo; Isaac Schwartz; Simona Zarini; Reena Bapputty; Timothy S Kern; Rose A Gubitosi-Klug; Robert C Murphy; M Cecilia Subauste; Carlos S Subauste
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-04       Impact factor: 4.799

4.  Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells.

Authors:  Jose-Andres C Portillo; Jin-Sang Yu; Sarah Vos; Reena Bapputty; Yalitza Lopez Corcino; Alyssa Hubal; Jad Daw; Sahil Arora; Wenyu Sun; Zheng-Rong Lu; Carlos S Subauste
Journal:  Diabetologia       Date:  2022-08-03       Impact factor: 10.460

5.  A cell-penetrating CD40-TRAF2,3 blocking peptide diminishes inflammation and neuronal loss after ischemia/reperfusion.

Authors:  Jose-Andres C Portillo; Jin-Sang Yu; Samuel Hansen; Timothy S Kern; M Cecilia Subauste; Carlos S Subauste
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.191

6.  CD40-TRAF Signaling Upregulates CX3CL1 and TNF-α in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells.

Authors:  Jennifer A Greene; Jose-Andres C Portillo; Yalitza Lopez Corcino; Carlos S Subauste
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

Review 7.  Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?

Authors:  Gustavo Ortiz; Juan P Salica; Eduardo H Chuluyan; Juan E Gallo
Journal:  Biol Res       Date:  2014-11-18       Impact factor: 5.612

8.  Loss of CD40 attenuates experimental diabetes-induced retinal inflammation but does not protect mice from electroretinogram defects.

Authors:  Ivy S Samuels; Jose-Andres C Portillo; Yanling Miao; Timothy S Kern; Carlos S Subauste
Journal:  Vis Neurosci       Date:  2017-01       Impact factor: 3.241

Review 9.  The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy.

Authors:  Matteo Tassetto; Anna Scialdone; Anna Solini; Francesco Di Virgilio
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

10.  Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.

Authors:  Yousof Taghavi; Gholamhossein Hassanshahi; Nicholas G Kounis; Ioanna Koniari; Hossein Khorramdelazad
Journal:  J Cell Commun Signal       Date:  2019-01-03       Impact factor: 5.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.